TG THERAPEUTICS, INC. Amortization of Debt Issuance Costs
TG THERAPEUTICS, INC. (TGTX) reported Amortization of Debt Issuance Costs of $532.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-05
- TG THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2026-06-30 was $247.00K, a 18.75% decline year-over-year.
- TG THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2026-03-31 was $285.00K, a 6.25% decline year-over-year.
- TG THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2025-12-31 was $304.00K, a 0.33% increase year-over-year.
- TG THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2025-09-30 was $304.00K, a 26.57% decline year-over-year.
- TG THERAPEUTICS, INC. amortization of debt issuance costs for fiscal 2025 was $1.22M, a 39.05% decline from fiscal 2024.
- TG THERAPEUTICS, INC. amortization of debt issuance costs for fiscal 2024 was $2.00M, a 16.11% decline from fiscal 2023.
- TG THERAPEUTICS, INC. amortization of debt issuance costs for fiscal 2023 was $2.38M, a 28.96% increase from fiscal 2022.
- TG THERAPEUTICS, INC. amortization of debt issuance costs for fiscal 2022 was $1.84M, a 70.74% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 21 month |
|---|---|---|---|---|---|
| 2026-06-30 | $247.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $532.00K 10-Q · filed 2026-08-05 | $836.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.14M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $285.00K 10-Q · filed 2026-05-06 | $589.00K derived: sum of 2 quarters · filed 2026-05-06 | $893.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.20M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $608.00K derived: sum of 2 quarters · filed 2026-02-27 | $912.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.22M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $304.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $608.00K derived: sum of 2 quarters · filed 2026-08-05 | $912.00K 10-Q · filed 2025-11-05 | $1.22M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $304.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $608.00K 10-Q · filed 2026-08-05 | $911.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.32M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $304.00K 10-Q · filed 2026-05-06 | $607.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.02M derived: sum of 3 quarters · filed 2026-05-06 | $1.66M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $303.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $717.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.36M derived: sum of 3 quarters · filed 2026-02-27 | $2.00M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $414.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.05M derived: sum of 2 quarters · filed 2025-11-05 | $1.69M 10-Q · filed 2025-11-05 | $2.33M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $639.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $1.28M 10-Q · filed 2025-08-08 | $1.92M derived: sum of 3 quarters · filed 2026-02-27 | $2.56M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $639.00K 10-Q · filed 2025-05-09 | $1.28M derived: sum of 2 quarters · filed 2026-02-27 | $1.92M derived: sum of 3 quarters · filed 2026-02-27 | $2.56M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $639.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.28M derived: sum of 2 quarters · filed 2026-02-27 | $1.92M derived: sum of 3 quarters · filed 2026-02-27 | $2.38M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $639.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.28M derived: sum of 2 quarters · filed 2024-11-07 | $1.74M 10-Q · filed 2024-11-07 | $2.20M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $639.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.10M 10-Q · filed 2024-08-09 | $1.56M derived: sum of 3 quarters · filed 2025-03-03 | $2.02M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $461.00K 10-Q · filed 2024-05-06 | $922.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.38M derived: sum of 3 quarters · filed 2025-03-03 | $1.84M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2022-12-31 | $461.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $922.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.38M derived: sum of 3 quarters · filed 2025-03-03 | $1.84M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $461.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $922.00K derived: sum of 2 quarters · filed 2023-11-06 | $1.38M 10-Q · filed 2023-11-06 | $1.77M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $461.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $922.00K 10-Q · filed 2023-08-04 | $1.31M derived: sum of 3 quarters · filed 2024-02-29 | $1.61M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $461.00K 10-Q · filed 2023-05-08 | $847.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.15M derived: sum of 3 quarters · filed 2024-02-29 | $1.38M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $686.00K derived: sum of 2 quarters · filed 2024-02-29 | $918.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.08M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $300.00K 10-Q · filed 2021-11-08 | $532.00K derived: sum of 2 quarters · filed 2022-08-09 | $694.00K 10-Q · filed 2022-11-09 | $994.00K derived: sum of 4 quarters · filed 2023-03-01 | $700.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $232.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $463.00K 10-Q · filed 2022-08-09 | $694.00K derived: sum of 3 quarters · filed 2023-03-01 | $894.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $231.00K 10-Q · filed 2022-05-10 | $462.00K derived: sum of 2 quarters · filed 2023-03-01 | $662.00K derived: sum of 3 quarters · filed 2023-03-01 | $894.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $431.00K derived: sum of 2 quarters · filed 2023-03-01 | $663.00K derived: sum of 3 quarters · filed 2023-03-01 | $925.00K 10-K · filed 2023-03-01 | |
| 2020-09-30 | $200.00K 10-Q · filed 2021-11-08 | $432.00K derived: sum of 2 quarters · filed 2021-11-08 | $694.00K 10-Q · filed 2021-11-08 | $896.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $232.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $463.00K 10-Q · filed 2021-08-06 | $696.00K derived: sum of 3 quarters · filed 2022-03-01 | $896.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $231.00K 10-Q · filed 2021-05-10 | $464.00K derived: sum of 2 quarters · filed 2022-03-01 | $664.00K derived: sum of 3 quarters · filed 2022-03-01 | $864.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $433.00K derived: sum of 2 quarters · filed 2022-03-01 | $633.00K derived: sum of 3 quarters · filed 2022-03-01 | $772.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $200.00K 10-Q · filed 2019-11-12 | $400.00K derived: sum of 2 quarters · filed 2019-11-12 | $539.00K 10-Q · filed 2020-11-09 | $477.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $200.00K 10-Q · filed 2019-08-09 | $308.00K 10-Q · filed 2020-08-10 | $277.00K derived: sum of 3 quarters · filed 2021-03-01 | $277.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $77.00K 10-Q · filed 2020-05-11 | $77.00K derived: sum of 2 quarters · filed 2021-03-01 | $77.00K derived: sum of 3 quarters · filed 2021-03-01 | $77.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-10 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-03-02 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | ||||
| 2014-03-31 | $427.81K 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |